Skip to main content
All lobbying filings

S-3 GROUP

Lobbying for SANDOZ INC. · Provider of "off patent" medicines

 Filing Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 17, 2026
Income
$80,000.00
What the client paid this registrant for the period.
Client based in
New Jersey

Official filing document

 Lobbyists on this filing 7
  • MARTIN DELGADO
    Previously held: Staff Dir, House Ag Approps, MilCon/VA Approps; Prof Staff, House Ag Approps, Senate Interior Approps; Budget Analysis, USDA APHIS
  • MICHAELEEN EARLE CROWELL
    Previously held: Leg Director, Rep. Denise Majette; Leg Director, Rep. John Lewis; Chief of Staff, US Sen. Bernie Sanders
  • MARTIN REISER
    Previously held: Policy Director, Republican Whip Steve Scalise, professional staff House Ways and Means Committee, Chief of Staff, Rep. Dan Miller, Budget Associate, House Budget Committee
  • OLIVIA KURTZ
    Previously held: Chief of Staff, Leg Director, Dep Leg Director, Sr Leg Asst, US Sen Susan Collins; Dep Staff Dir, Sen Special Comm on Aging; Leg Director, Sr Leg Asst, Leg Asst, Exec Asst, Rep Mike Castle
  • CHANDA BETOURNEY
    Previously held: Dep. Staff Director and Chief Counsel, Senate Appropriations Cmt; Chief Counsel Civil Law and Oversight, Sen. Counsel, Sen. Judiciary Cmt; Leg Asst. and Projects Dir., Leg. Corresp., Senator Leahy
  • KRISTI REMINGTON
    Previously held: Deputy Assistant Attorney General, US Department of Justice; Senior Counsel, House Government Reform Committee
  • CHRISTOPHER BUKI New on this filing
    Previously held: Staff Assistant/Legislative Correspondent, Representative John Culberson; Legislative Assistant/Senior Legislative Assistant, Representative Bill Shuster; Legislative Director/Deputy Chief of Staff, Representative David McKinley

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Issues and legislative proposals on biosimilars and generics medicines, including but not limited to generics and biosimilar sustainability, pharmaceutical supply chain security, drug shortages, interchangeability, patent litigation, and PBM reform

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem